Table 2 Indication for bronchoscopy and the use of sedative drugs
Remifentanil group (n = 111) | Midazolam / propofol group (n = 75) | p | |
|---|---|---|---|
Indication for bronchoscopy | 0.137 | ||
Infection | 45 (40.5) | 40 (53.3) | |
Lung cancer | 19 (17.1) | 6 (8.0) | |
Hemoptysis | 13 (11.7) | 12 (16.0) | |
Interstitial lung disease | 2 (1.8) | 0 (0) | |
Others | 32 (28.8) | 17 (22.7) | |
Procedure | 0.005 | ||
Endobronchial inspection only | 81 (73.0) | 70 (93.3) | |
Endobronchial inspection with bronchoscopic biopsy | 20 (18.0) | 1 (1.3) | |
Endobronchial inspection with BAL and TBLB | 2 (1.8) | 0 (0.0) | |
Endobronchial inspection with BAL | 8 (7.2) | 4 (5.3) | |
Procedure duration, min | 9 (8–10) | 11 (10–13) | < 0.001 |
Sedative drugs | |||
Midazolam dose, mg | – | 2 (0–4) | |
Propofol dose rate, ug/kg/min | – | 50.2 (39.0–64.3) | |
Remifentanil dose rate, ug/kg/min | 0.2 (0.2–0.3) | ||